SCHEMBL17264241

SCHEMBL17264241

O=C1OCc2c(O)ccc(-c3ccccc3)c21

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 7/20 0.44
HDAC4 P56524 1/20 0.42
HDAC2 Q92769 1/20 0.42
HDAC8 Q9BY41 1/20 0.42
HDAC6 Q9UBN7 1/20 0.42
KMT2A Q03164 2/20 0.41
MMP2 P08253 1/20 0.40
MMP3 P08254 1/20 0.40
MMP9 P14780 1/20 0.40
BACE1 P56817 1/20 0.39
ADORA3 P0DMS8 1/20 0.39
ADORA2A P29274 1/20 0.39
ADORA1 P30542 1/20 0.39
ALDH1A1 P00352 2/20 0.39
HPGD P15428 2/20 0.39
HSD17B10 Q99714 2/20 0.39
ALOX15 P16050 2/20 0.39
ALOX12 P18054 2/20 0.39
MAOA P21397 2/20 0.39
KDM4E B2RXH2 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7002194 0.80 MAOA (0.53) ALOX5KMT2AALDH1A1HPGDHSD17B10
SCHEMBL12553313 0.73 ALOX5 (0.48) ALOX5KMT2AMAOANUAK1IGF1R
SCHEMBL27988072 0.70 MAOA (0.57) ALOX5HDAC4HDAC2HDAC8HDAC6
SCHEMBL27987728 0.69 ALOX5 (0.50) ALOX5KMT2AALDH1A1HPGDHSD17B10
SCHEMBL2080972 0.69 ALOX5 (0.50) ALOX5KMT2AALDH1A1HPGDHSD17B10
SCHEMBL10788448 0.69 BACE1 (0.50) ALOX5HDAC4HDAC2HDAC8HDAC6
SCHEMBL11257546 0.68 BACE1 (0.41) ALOX5KMT2ABACE1ADORA3ADORA2A
SCHEMBL217083 0.68 BACE1 (0.54) ALOX5HDAC4HDAC2HDAC8HDAC6
SCHEMBL29793269 0.67 MAOB (0.47) ALDH1A1HPGDHSD17B10ALOX15MAOA
SCHEMBL78594 0.67 MAOB (0.47) ALDH1A1HPGDHSD17B10ALOX15MAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150328245-A1 Agents for Eliminating Tumour-Initiating Cells GODAVARI BIOREFINERIES LIMITED (IN) 2015-11-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150328245-A1 Agents for Eliminating Tumour-Initiating Cells MCL1, CD47, CD44 ALOX5 272/4885HDAC4 932/4885HDAC2 2368/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.